Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank71
3Y CAGR+11.3%
5Y CAGR+2.2%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+11.3%/yr
vs -37.0%/yr prior
5Y CAGR
+2.2%/yr
Recent acceleration
Acceleration
+48.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.60 | +68.6% |
| 2024 | 3.32 | +16.3% |
| 2023 | 2.85 | -29.6% |
| 2022 | 4.06 | +11.6% |
| 2021 | 3.63 | -27.7% |
| 2020 | 5.03 | +51.3% |
| 2019 | 3.32 | -87.1% |
| 2018 | 25.83 | +477.1% |
| 2017 | 4.48 | +162.0% |
| 2016 | 1.71 | - |